Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.01 USD | -1.23% | +0.50% | -1.48% |
20/06 | JMP Securities Adjusts Price Target on Iovance Biotherapeutics to $23 From $25, Maintains Market Outperform Rating | MT |
11/06 | Iovance Biotherapeutics, Inc. Elects Frederick G. Vogt as Director | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.48% | 2.27B | |
-39.86% | 8.15B | |
+7.39% | 3.6B | |
-26.02% | 1.9B | |
-20.07% | 1.72B | |
+8.09% | 922M | |
+19.92% | 731M | |
-12.45% | 679M | |
-29.39% | 503M | |
-1.89% | 288M |
- Stock Market
- Equities
- IOVA Stock
- News Iovance Biotherapeutics, Inc.
- JMP Securities Adjusts Price Target on Iovance Biotherapeutics to $23 From $25, Maintains Market Outperform Rating